Potential associated risk factors of urinary tract infection in female patients with SLE
| Variables | Univariate analysis OR (95% CI) | P value | Multivariate analysis OR (95% CI) | P value |
| TMP-SMX prophylaxis | 16 (2.92 to 87.70) | 0.001 | 30.96 (3.63 to 264.11) | 0.002 |
| Serum C3 level | 12.75 (1.21 to 133.83) | 0.034 | 35.33 (1.33 to 936.67) | 0.033 |
| Vaginal microbiota | ||||
| Enterococcus spp | 3.472 (1.04 to 11.55) | 0.042 | 5.53 (0.93 to 32.96) | 0.060 |
| Veillonella dispar | 4.37 (1.29 to 14.73) | 0.018 | 6.68 (1.27 to 35.07) | 0.025 |
| Peptostreptococcus spp | 3.29 (1.00 to 10.79) | 0.05 | – | – |
TMP-SMX, trimethoprim-sulfamethoxazole.